Canagliflozin reduces atherosclerosis and modulates inflammatory, oxidative pathways in mice

  • Post author:
  • Post category:uncategorized

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This study was aimed at investigating the effect of canagliflozin (Cana) on atherosclerosis and further exploring its potential mechanism.…

Continue ReadingCanagliflozin reduces atherosclerosis and modulates inflammatory, oxidative pathways in mice